忘備録
ミフェプリストン（RU 486）の最初の臨床試験がスイスで開始されたことは、以下の文献で確認できます。
典拠文献
Magon N, Kalra S. "The many lives of mifepristone: Multi-glandular exaptation of an endocrine molecule." Indian J Endocrinol Metab. 2011;15 Suppl 1:S1-S5.
記述内容: 1981年にエティエンヌ＝エミール・ボリュー（Etienne-Emile Baulieu）が、スイスのジュネーブ大学病院の産婦人科医ウォルター・ハーマン（Walter Herrmann）に試験を依頼。1982年4月に成功が発表された旨が記されています。
Clinical tests of the pill, dubbed R(oussel)U(claf)-486, began in Switzerland in 1982 under the direction of Walter Herman, a long-time friend of Baulieu (Rosenfeld, 1986). In 1983 Gilbert Schaison and Beatrice Couzinet at Bicêtre Hospital in Paris also began tests. There was little opposition to the tests because they had been cleared by the French national bioethics committee (Nayeri, 1987).
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3401788/
Institute of Medicine (US) Committee on Antiprogestins. "A Political History of RU-486." Biomedical Politics. Washington (DC): National Academies Press (US); 1991.
記述内容: 第1相および第2相試験が1981年から1982年にかけてスイスのジュネーブで開始された歴史的経緯が詳述されています。
In 1981, endocrinologist Etienne-Emile Baulieu arranged testing it for its use for medical abortion in Switzerland by gynecologist Walter Herrmann. It was tested at University of Geneva's Cantonal Hospital, with successful results announced in April 1982. In 1987, following worldwide clinical trials in 20,000 women, of mifepristone with misoprostol for medical abortion, Roussel-Uclaf sought approval in France for their use for medical abortion, which was announced in September 1988.
